According to The Insight Partners, the Daptomycin Market is projected to grow from US$ 3.48 Billion in 2025 to US$ 4.52 Billion by 2034, registering a CAGR of 3.32% during the forecast period from 2026 to 2034. Market Overview Daptomycin is a cyclic lipopeptide antibiotic widely used in the treatment of complicated skin and soft tissue infections, bacteremia, and right-sided infective...